comparemela.com

Latest Breaking News On - Focus capital management - Page 4 : comparemela.com

Oportun Financial Co (NASDAQ:OPRT) Given Average Rating of Moderate Buy by Brokerages

Shares of Oportun Financial Co. (NASDAQ:OPRT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year […]

Oportun Financial Co (NASDAQ:OPRT) Receives $7 25 Average Target Price from Analysts

Oportun Financial Co. (NASDAQ:OPRT – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among […]

Cellectis S A (NASDAQ:CLLS) Shares Sold by Baillie Gifford & Co

Baillie Gifford & Co. decreased its holdings in shares of Cellectis S.A. (NASDAQ:CLLS – Free Report) by 13.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,418,996 shares of the biotechnology company’s stock after selling 220,900 shares during the quarter. Baillie Gifford […]

FREYR Battery (NYSE:FREY) Reaches New 1-Year Low at $4 72

FREYR Battery (NYSE:FREY – Get Free Report)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as $4.72 and last traded at $4.76, with a volume of 240183 shares changing hands. The stock had previously closed at $4.89. Analysts Set New Price Targets FREY has been the […]

Cellectis (NASDAQ:CLLS) Coverage Initiated at StockNews com

StockNews.com started coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a report issued on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. A number of other analysts have also commented on the stock. JMP Securities restated a market outperform rating and set a $6.00 price target on shares of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.